Deccan Chronicle

Shorter All-oral Regimens for Drug-Resistant TB are Cost-Effective in India: ICMR Study

The analysis revealed that the BPaL regimen is both more effective and cost-saving. For each additional Quality Adjusted Life Year (QALY) gained, the health system spends INR 379 less per patient compared to the standard regimen, indicating better health outcomes at lower costs